Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes

被引:61
作者
Besser, Rachel E. J. [1 ]
Ludvigsson, Johnny [2 ]
Jones, Angus G. [1 ]
McDonald, Timothy J. [1 ,3 ]
Shields, Beverley M. [1 ]
Knight, Bridget A. [1 ]
Hattersley, Andrew T. [1 ]
机构
[1] Univ Exeter, Peninsula Med Sch, Peninsula Natl Inst Hlth Res Clin Res Facil, Exeter, Devon, England
[2] Linkoping Univ, Div Pediat, Dept Clin & Expt Med, Linkoping, Sweden
[3] Royal Devon & Exeter NHS Fdn Trust, Dept Clin Biochem, Exeter, Devon, England
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
BETA-CELL FUNCTION; INSULIN; PLASMA;
D O I
10.2337/dc10-2114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Stimulated serum C-peptide (sCP) during a mixed-meal tolerance test (MMTT) is the gold standard measure of endogenous insulin secretion, but practical issues limit its use. We assessed urine C-peptide creatinine ratio (UCPCR) as an alternative. RESEARCH DESIGN AND METHODS-Seventy-two type 1 diabetic patients (age of diagnosis median 14 years [interquartile range 10-22]; diabetes duration 6.5[2.3-32.7]) had an MMTT. sCP was collected at 90 min. Urine for UCPCR was collected at 120 min and following a home evening meal. RESULTS-MMTT 120-min UCPCR was highly correlated to 90-min sCP (r = 0.97; P < 0.0001). UCPCR >= 0.53 nmol/mmol had 94% sensitivity/100% specificity for significant endogenous insulin secretion (90-min sCP >= 0.2 nmol/L). The 120-min postprandial evening meal UCPCR was highly correlated to 90-min sCP (r = 0.91; P < 0.0001). UCPCR >= 0.37 nmol/mmol had 84% sensitivity/97% specificity for sCP >= 0.2 nmol/L. CONCLUSIONS-UCPCR testing is a sensitive and specific method for detecting insulin secretion. UCPCR may be a practical alternative to serum C-peptide testing, avoiding the need for inpatient investigation.
引用
收藏
页码:607 / 609
页数:3
相关论文
共 13 条
[1]   RESIDUAL B-CELL FUNCTION IN DIABETIC CHILDREN AS DETERMINED BY URINARY C-PEPTIDE [J].
AURBACHKLIPPER, J ;
SHARPHDOR, R ;
HEDING, LG ;
KARP, M ;
LARON, Z .
DIABETOLOGIA, 1983, 24 (02) :88-90
[2]   Assays for insulin, proinsulin(s) and C-peptide [J].
Clark, PM .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :541-564
[4]   CORRELATIONS BETWEEN FASTING PLASMA C-PEPTIDE, GLUCAGON-STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN INSULIN-TREATED DIABETICS [J].
GJESSING, HJ ;
MATZEN, LE ;
FROLAND, A ;
FABER, OK .
DIABETES CARE, 1987, 10 (04) :487-490
[5]   Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes [J].
Greenbaum, Carla J. ;
Mandrup-Poulsen, Thomas ;
Friedenberg, Paula ;
Battelino, Tadej ;
Haastert, Burkhard ;
Ludvigsson, Johnny ;
Pozzilli, Paolo ;
Lachin, John M. ;
Kolb, Hubert .
DIABETES CARE, 2008, 31 (10) :1966-1971
[6]   ISPAD Clinical Practice Consensus Guidelines 2006-2007 - The diagnosis and management of monogenic diabetes in children [J].
Hattersley, Andrew ;
Bruining, Jan ;
Shield, Julian ;
Njolstad, Pal ;
Donaghue, Kim .
PEDIATRIC DIABETES, 2006, 7 (06) :352-360
[7]   CLINICAL-SIGNIFICANCE OF URINARY C-PEPTIDE EXCRETION IN CHILDREN WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HUTTUNEN, NP ;
KNIP, M ;
KAAR, ML ;
PUUKKA, R ;
AKERBLOM, HK .
ACTA PAEDIATRICA SCANDINAVICA, 1989, 78 (02) :271-277
[8]   PLASMA AND URINARY C-PEPTIDE IN THE CLASSIFICATION OF ADULT DIABETICS [J].
KOSKINEN, P ;
VIIKARI, J ;
IRJALA, K ;
KAIHOLA, HL ;
SEPPALA, P .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1986, 46 (07) :655-663
[9]   Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide [J].
McDonald, Tim J. ;
Knight, Bridget A. ;
Shields, Beverley M. ;
Bowman, Pamela ;
Salzmann, Maurice B. ;
Hattersley, Andrew T. .
CLINICAL CHEMISTRY, 2009, 55 (11) :2035-2039
[10]   Five-year follow-up after clinical islet transplantation [J].
Ryan, EA ;
Paty, BW ;
Senior, PA ;
Bigam, D ;
Alfadhli, E ;
Kneteman, NM ;
Lakey, JRT ;
Shapir, AMJ .
DIABETES, 2005, 54 (07) :2060-2069